Moexipril - CISMeF

Preferred Label : Moexipril;

NCIt definition : A non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, moexipril is hydrolyzed into its active form moexiprilat, which competitively inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the actions of the potent vasoconstrictor angiotensin II and leads to vasodilation. It also prevents angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis.;

UNII : WT87C52TJZ;

InChIKey : UWWDHYUMIORJTA-HSQYWUDLSA-N;

CAS number : 103775-10-6;

Chemical formula : C27H34N2O7;

Détails

Origin ID

C83967;

UMLS CUI

C0066685;

Currated CISMeF NLP mapping
- Moexipril [ICD-11 Extension code]
- Moexipril [SMS substance]
- Moexipril (substance) [SNOMED CT concept]
- moexipril [MeSH concept]
- moexipril [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Moexipril (substance) [SNOMED CT concept]
- Product containing moexipril (medicinal product) [SNOMED CT concept]
- moexipril [ATC Code]
- moexipril [MeSH Supplementary Concept]
- moexipril [MeSH concept]
Validated automatic mappings to BTNT
- moexipril [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Moexipril Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Moexipril Hydrochloride [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients